![]()
|
Report Date : |
18.10.2011 |
IDENTIFICATION DETAILS
|
Name : |
TATVA CHINTAN PHARMA CHEM PRIVATE LIMITED |
|
|
|
|
Registered Office : |
Laxmi Bhavan, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2010 |
|
|
|
|
Date of Incorporation : |
12.06.1996 |
|
|
|
|
Com. Reg. No.: |
04-29894 |
|
|
|
|
Capital Investment / Paid-up Capital : |
Rs.32.319 millions |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24232GJ1996PTC029894 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
BRDT00509F |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AABCT0623N |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturer of Phase Transfer Catalysts and Organic Quaternary
Ammonium Compounds. |
|
|
|
|
No. of Employees : |
120 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (49) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
|
|
|
|
Maximum Credit Limit : |
USD 192100 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track. Trade relations
are reported as fair. Business is active. Payments are reported to be usually
correct and as per commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – April 1, 2010
|
Country Name |
Previous Rating (31.12.2009) |
Current Rating (01.04.2010) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Mr. Chintan Nitinkumar Shah |
|
Designation : |
Director |
|
Contact No.: |
91-9825153445 |
|
Date : |
12.10.2011 |
LOCATIONS
|
Registered Office : |
Laxmi Bhavan, |
|
Tel. No.: |
91-265-2437093 |
|
Mobile No.: |
91-9974249904 (Mr. Chetan Sheth), 91-9825445675 (Mr. Shekhar R Somani
) |
|
Fax No.: |
91-265-2424495 |
|
E-Mail : |
info@tatvachintan.com |
|
Website : |
|
|
Area : |
1000 Sq. ft. |
|
Location : |
Owned |
|
|
|
|
Factory : |
502/17, G.I.D.C Estate, Ankleshwar – 393 002, |
|
Tel. No.: |
91-2646-253593 / 238991 |
|
Fax No.: |
91-2646-238992 |
|
E-Mail : |
chintan@tatvachintan.com
|
|
Area : |
3000 Sq. ft. |
|
Location : |
Owned |
DIRECTORS
AS ON 23.09.2010
|
Name : |
Mr. Chintan Nitinkumar Shah |
|
Designation : |
Director |
|
Address : |
11-12, Sudhan Laxmi Jain Society, Subhanpura, |
|
Date of Birth/Age : |
29.04.1973 |
|
Qualification : |
B.E. (Computer Science) |
|
Date of Appointment : |
12.06.1996 |
Other Directorship:
|
S.No. |
CIN |
Name of the Company |
Current designation of the director |
Date of appointment at current designation |
Original date of appointment |
Date of cessation |
Company Status |
Defaulting status |
|
1 |
U24232GJ1996PTC029894 |
TATVA CHINTAN PHARMA CHEM
PRIVATE LIMITED |
Director |
12/06/1996 |
12/06/1996 |
- |
Active |
NO |
|
2 |
U24231GJ2003PTC042991 |
CATALYST ORGANICS PRIVATE
LIMITED |
Director |
01/10/2003 |
01/10/2003 |
- |
Active |
NO |
|
Name : |
Mr. Ajaykumar Mansukhlal Patel |
|
Designation : |
Director |
|
Address : |
9-645 Wadi Falia, Siddhmatani Sheri, |
|
Date of Birth/Age : |
27.02.1972 |
|
Qualification : |
B.E. (Chemical) |
|
Date of Appointment : |
12.06.1996 |
Other Directorship:
|
S.No. |
CIN |
Name of the Company |
Current designation of the director |
Date of appointment at current designation |
Original date of appointment |
Date of cessation |
Company Status |
Defaulting status |
|
1 |
U24232GJ1996PTC029894 |
TATVA CHINTAN PHARMA CHEM
PRIVATE LIMITED |
Director |
12/06/1996 |
12/06/1996 |
- |
Active |
NO |
|
2 |
U24231GJ2003PTC042991 |
CATALYST ORGANICS PRIVATE
LIMITED |
Director |
01/10/2003 |
01/10/2003 |
- |
Active |
NO |
|
Name : |
Mr. Shekhar Rasiklal Somani |
|
Designation : |
Director |
|
Address : |
Mahavir Society, 51-52, 202 Mahavir Apartment, Zaveri Sadak, Navasari
– 396 445, |
|
Date of Birth/Age : |
11.01.1974 |
|
Qualification : |
(B. Pharma) Young Entrepreneurs |
|
Date of Appointment : |
12.06.1996 |
Other Directorship:
|
S.No. |
CIN |
Name of the Company |
Current designation of the director |
Date of appointment at current designation |
Original date of appointment |
Date of cessation |
Company Status |
Defaulting status |
|
1 |
U24232GJ1996PTC029894 |
TATVA CHINTAN PHARMA CHEM
PRIVATE LIMITED |
Director |
12/06/1996 |
12/06/1996 |
- |
Active |
NO |
|
2 |
U24231GJ2003PTC042991 |
CATALYST ORGANICS PRIVATE
LIMITED |
Director |
01/10/2003 |
01/10/2003 |
- |
Active |
NO |
KEY EXECUTIVES
|
Name : |
M/S J J Gandhi and Company |
|
Designation : |
Company Secretary |
|
Address : |
231, Pheonix Complex, Besides |
|
Tel. No.: |
91-265-2225022 |
|
Mobile No.: |
91-9879020625/ 937420085 |
|
E-Mail : |
Other Directorship:
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 23.09.2010
|
Names of Shareholders |
No. of Shares |
|
Chintan Shah |
816014 |
|
Ajay Patel |
727193 |
|
Shekhar Somani |
833673 |
|
Rasiklal Somani |
99660 |
|
Dashnaben Shah |
147400 |
|
Priti Patel |
257400 |
|
Kajal Somani |
62260 |
|
Shital Shah |
92400 |
|
Raxaben Patel |
92400 |
|
Ranjanben Somani |
52800 |
|
Sheetal Somani |
4400 |
|
Samir Somani |
24200 |
|
Chintan N Shah (HUF) |
22000 |
|
Pravin Candra and Company, Mumbai |
100 |
|
Total
|
3231900 |
Equity share
breakup (percentage of total equity)
AS ON 23.09.2010
|
Category |
Percentage |
|
Directors or relatives of directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Phase Transfer Catalysts and Organic Quaternary
Ammonium Compounds. |
||||
|
|
|
||||
|
Products : |
·
Phase Transfer Catalysts ·
Glycol Diethers ·
Ionic Liquids ·
Ester Acetates ·
Bulk APls |
||||
|
|
|
||||
|
Exports : |
|
||||
|
Products : |
Chemical and Pharmaceutical Products |
||||
|
Countries : |
·
·
·
·
·
·
·
·
·
UAE etc. |
||||
|
|
|
||||
|
Imports : |
|
||||
|
Products : |
Raw Materials |
||||
|
Countries : |
·
·
·
USA |
||||
|
|
|
||||
|
Terms : |
|
||||
|
Selling : |
L/C, Cash, Credit (30 days,60 days)
|
||||
|
|
|
||||
|
Purchasing : |
L/C, Cash, Credit (30 days,60 days)
|
PRODUCTION STATUS (AS ON
31.03.2010):-
Installed
Capacity: 1500 MTPA
|
Particulars |
|
Unit |
Actual
Production |
|
Quaternary Compounds |
|
MT |
748.602 |
|
Glymes |
|
MT |
4.664 |
|
Bulk Drugs |
|
MT |
229.593 |
|
Specialty Chemicals |
|
MT |
26.165 |
|
Recovered Mix Solvent |
|
mT |
386.476 |
GENERAL INFORMATION
|
Customers : |
OEM’s |
||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
No. of Employees : |
120 (Approximately) |
||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
Bank of |
||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
Facilities : |
|
||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
Banking
Relations : |
-- |
||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
Auditors : |
|
||||||||||||||||||||||||||||||||||||||||
|
Name : |
Pathak Anjaria and Company Chartered Accountants (Mr. Premal J Pathak, Partner, M. No. 42634) |
||||||||||||||||||||||||||||||||||||||||
|
Address : |
2nd Floor, Leela Sadan, Vadodara – 390 001, |
||||||||||||||||||||||||||||||||||||||||
|
Tel No.: |
91-265-6538755 |
||||||||||||||||||||||||||||||||||||||||
|
Mobile No.: |
91-9824016006 |
||||||||||||||||||||||||||||||||||||||||
|
Fax No.: |
91-265-2420455 |
||||||||||||||||||||||||||||||||||||||||
|
Email : |
|||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
Memberships : |
Chemicals and Allied Products Export Promotion Council (CHEMEXCIL) |
||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
Sister Concern : |
Tatva Chintan Laboratories Address: 502/17, GIDC, Ankleshwar – 393 002, Year of Establishment : 1992 Activity : Manufacturers Sodium Citrate, Potassium
Citrate, Sodium Acid, Citrate, Methyl Parabens, Propyl Paruben, Sodium Methyl
Paraben, Sodium Propyl Paraben, etc. |
CAPITAL STRUCTURE
As on 31.03.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
4000000 |
Equity Shares |
Rs.10/- each |
Rs.30.000 millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
3231900 |
Equity Shares |
Rs.10/- each |
Rs.32.319 millions |
|
|
|
|
|
NoteS:
2119800 Equity Shares of Rs. 10/- each are
allotted as fully paid – up bonus shares by way of capitalization of
accumulated profits.
FINANCIAL DATA
[all figures are
in Rupees Millions]
|
Particulars |
|
|
31.03.2011 |
|
Sales Turnover (Approximately) |
|
|
400.000 |
Expected Sales (2011-2012) : Rs.500.000 Millions
The above information has been parted by Mr. Chintan Nitinkumar Shah (Director)
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
32.319 |
30.000 |
9.999 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
15.706 |
9.394 |
17.019 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
46.025 |
39.394 |
27.018 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
107.726 |
60.303 |
37.220 |
|
|
2] Unsecured Loans |
13.735 |
7.541 |
11.370 |
|
|
TOTAL BORROWING |
121.461 |
67.844 |
48.590 |
|
|
DEFERRED TAX LIABILITIES |
5.893 |
4.075 |
3.205 |
|
|
|
|
|
|
|
|
TOTAL |
173.379 |
111.313 |
78.813 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
88.202 |
47.818 |
34.760 |
|
|
Capital work-in-progress |
0.000 |
1.364 |
0.353 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
58.784
|
35.276
|
30.766
|
|
|
Sundry Debtors |
55.048
|
57.363
|
36.593
|
|
|
Cash & Bank Balances |
12.517
|
7.341
|
2.607
|
|
|
Other Current Assets |
0.000
|
0.000
|
0.000
|
|
|
Loans & Advances |
22.226
|
12.124
|
7.949
|
|
Total
Current Assets |
148.575
|
112.104
|
77.915
|
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
58.618
|
47.649
|
33.346
|
|
|
Other Current Liabilities |
1.139
|
0.748
|
0.670
|
|
|
Provisions |
1.865
|
1.768
|
0.211
|
|
Total
Current Liabilities |
61.622
|
50.165
|
34.227
|
|
|
Net Current Assets |
86.953
|
61.939
|
43.688
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.224 |
0.192 |
0.012 |
|
|
|
|
|
|
|
|
TOTAL |
173.379 |
111.313 |
78.813 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
282.797 |
239.379 |
166.397 |
|
|
|
Other Income |
|
2.443 |
1.640 |
|
|
|
TOTAL (A) |
282.797 |
241.822 |
168.037 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Raw Material Consumed |
|
147.058 |
103.489 |
|
|
|
Other Manufacturing Expenses |
|
22.190 |
14.862 |
|
|
|
Remuneration to Personal |
|
12.998 |
9.874 |
|
|
|
Excise Duty |
|
20.437 |
18.337 |
|
|
|
Selling and Administrative Expenses |
|
12.630 |
10.608 |
|
|
|
Loss of Fixed Assets |
|
0.994 |
0.474 |
|
|
|
Increased/(Decreased) in Stock |
|
1.633 |
(8.344) |
|
|
|
TOTAL (B) |
255.927 |
217.940 |
149.300 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
26.870 |
23.882 |
18.737 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
10.309 |
5.978 |
5.521 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
16.561 |
17.904 |
13.216 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
3.848 |
2.059 |
1.728 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
12.713 |
15.845 |
11.488 |
|
|
|
|
|
|
|
|
|
Less |
TAX (I) |
3.867 |
5.479 |
3.690 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-I) (J) |
8.846 |
10.366 |
7.798 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
9.395 |
17.019 |
9.561 |
|
|
|
|
|
|
|
|
|
Add |
PRIOR
PERIOD ADJUSTMENTS |
(0.669) |
(0.035) |
0.244 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Bonus Shares |
0.000 |
16.200 |
0.000 |
|
|
|
Dividend |
1.616 |
1.500 |
0.499 |
|
|
|
Income Tax on Dividend |
0.249 |
0.254 |
0.085 |
|
|
BALANCE CARRIED
TO THE B/S |
15.707 |
9.396 |
17.019 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
2.74 |
3.46 |
-- |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
PAT / Total Income |
(%) |
3.13
|
4.29
|
4.64
|
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
4.49
|
6.62
|
6.90
|
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
5.37
|
9.82
|
10.20
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.28
|
0.40
|
0.43
|
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
3.98
|
2.99
|
3.07
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.41
|
2.23
|
2.28
|
LOCAL AGENCY FURTHER INFORMATION
|
Check List by
Info Agents |
Available in
Report (Yes / No) |
|
1) Year of Establishment |
Yes |
|
2) Locality of the firm |
Yes |
|
3) Constitutions of the firm |
Yes |
|
4) Premises details |
Yes |
|
5) Type of Business |
Yes |
|
6) Line of Business |
Yes |
|
7) Promoter's background |
-- |
|
8) No. of employees |
Yes |
|
9) Name of person contacted |
Yes |
|
10) Designation of contact person |
Yes |
|
11) Turnover of firm for last three years |
Yes |
|
12) Profitability for last three years |
No |
|
13) Reasons for variation <> 20% |
No |
|
14) Estimation for coming financial year |
Yes |
|
15) Capital in the business |
No |
|
16) Details of sister concerns |
No |
|
17) Major suppliers |
No |
|
18) Major customers |
No |
|
19) Payments terms |
Yes |
|
20) Export / Import details (if
applicable) |
Yes |
|
21) Market information |
-- |
|
22) Litigations that the firm / promoter
involved in |
-- |
|
23) Banking Details |
Yes |
|
24) Banking facility details |
-- |
|
25) Conduct of the banking account |
-- |
|
26) Buyer visit details |
-- |
|
27) Financials, if provided |
No |
|
28) Incorporation details, if applicable |
-- |
|
29) Last accounts filed at ROC |
-- |
|
30) Major Shareholders, if available |
-- |
Form 8:-
|
Name of the company |
TATVA CHINTAN PHARMA CHEM PRIVATE LIMITED |
||||||||||||||||||
|
Presented By |
Bank of Tatvachintan Pharma Chem Private Limited |
||||||||||||||||||
|
1) Date and description of instrument creating the change |
Hypothecation
Agreement dated 28.04.2005 |
||||||||||||||||||
|
2) Amount secured by the charge/amount owing on the securities of charge |
Rs.22.950
millions
|
||||||||||||||||||
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
Term Loan Hypothecation of
plant, machinery and equipments to the Hypothecation Agreement, both present and
future, installed, situated and lying at Plot No. 502/17, GIDC, Ankleshwar. For Other limits Hypothecation of
all kinds of goods viz. Raw materials, WIP< Finished Goods lying at Plot
No. 502/17, GIDC, Ankleshwar and hypothecation of Book Debts and receivables
and goods procured under L/C. |
||||||||||||||||||
|
4) Gist of the terms and conditions and extent and operation of the charge. |
Margin Stocks –
25% Book Debts – 40% Interest Term Loan 2.75%
OBPLR p.a. monthly rest Cash Credit 2.00%
OBPLR p.a. monthly rest EPC – as per
bank’s guidelines Period Renewable
after one year. |
||||||||||||||||||
|
5) Name and Address and description of the person entitled to the charge. |
Bank of Industrial Estate
Branch, GIDC, Ankleshwar |
|
This form is for |
Modification of
charge |
|
Corporate
identity number of the company |
U24232GJ1996PTC029894 |
|
Name of the
company |
TATVA CHINTAN PHARMA CHEM PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in |
Laxmi Bhavan, |
|
Type of charge |
Immovable
property |
|
Particular of
charge holder |
Bank of Industrial Estate Branch, GIDC, Ankleshwar – 393 002, Email: indank@bankofbaroda.com |
|
Nature of
description of the instrument creating or modifying the charge |
Supplemental
Memorandum of Entry |
|
Date of
instrument Creating the charge |
05.05.2008 |
|
Amount secured by
the charge |
Rs.74.893
Millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest:
Term Loan : BPLR
p.a. with monthly rest Cash Credit : 1%
below BPLR Packing Credit Limit
: as per Bank guidelines Terms of
Repayment: Working Capital repayable on demand and Term Loans and Demand loan
repayable as per schedule loan agreement. Margin: 25% on all stocks 40% on all
eligible book debts 25% Term Loan 25% on Inland/
Import Letter Extent and
Operation of the charge: First charge on the immovable properties of the
company. |
|
Short particulars
of the property charged |
Land and Building situated at GIDC Plot No. 502/8, Plot No. 502/18
Revenue survey No. 271/p within the village limit of Piraman Tal. Ankleshwar
Dist. Bharuch |
|
This form is for |
Modification of
charge |
|
Charge
identification number of the modified |
90110934 |
|
Corporate
identity number of the company |
U24232GJ1996PTC029894 |
|
Name of the
company |
TATVA CHINTAN
PHARMA CHEM PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in |
|
|
Type of charge |
Book Debts Movable Property |
|
Particular of
charge holder |
Bank of |
|
Nature of
description of the instrument creating or modifying the charge |
Fourth
Supplemental Composite Agreement of Hypothecation of Goods, Book Debts, Movable
Machinery and Vehicles. |
|
Date of
instrument Creating the charge |
12/06/2009 |
|
Amount secured by
the charge |
Rs.115.413
Millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest Term Loan : BPLR
p.a. with monthly rest Cash Credit : 1%
below BPLR Packing Credit
Limit : as per Bank guidelines Terms of
Repayment Working capital
repayable on demand and Term loan repayable as per schedule of loan
agreement. Margin 25% on all stocks 40% on all
eligible book debts 25% Term Loan 25% on Inland /
Import Letter Extent and
Operation of the charge First charge on
the movable properties of the company |
|
Short particulars
of the property charged |
Borrower's stocks
both present and future including raw materials, work in process, semi
finished goods and finished goods such as chemicals, Pharmaceuticals Bulk
Drugs, Intermediates, speciality fine chemicals, packing materials, stores
etc. All present and future book debts, outstanding, money receivables, which
is due and owing to the borrower in the course of its business. All tangible
movable machineries and movable plants. |
|
Date of latest
modification prior to the present modification |
05/05/2008 |
|
Particulars of
the present modification |
The existing
charge was enhanced from Rs.74.893 Millions to Rs.115.413 Millions so as it
can secure the aggregate additional
finance facility of Rs.40.520 Millions. |
Fixed Assets
·
·
·
Labour Quarters
·
·
Plant and Machinery
·
Gas Cylinders
·
Electrical Installations
·
Effluent Treat Plant
·
Two Wheelers
·
Furniture and Fixtures
·
Computer
·
R and D Equipment
·
Motor Car
·
Office Equipments
·
R and D Building
Web Details
Company Profile
Subject is an integrated growing specialty chemical and
pharmaceutical company, promoted by three young and technocrats friends,
founded in 1996 with the purpose of serving the community and aiming to become
one of the fastest growing specialty chemical and pharmaceutical company in
India.
Strong business relationships, commitment to outstanding
quality and service make subject a preferred partner for its customers.
The company’s success is based on the expertise of its
people, their ability to identify new customer needs at an early stage, and an
enthusiasm to work together with customers to develop creative, efficient
solutions
Company Philosophy
They believe the first responsibility is to the customers who use the
products and services. In meeting their needs everything they do must be of
high quality. They must constantly strive to reduce the costs in order to
maintain reasonable prices. Customer orders must be serviced promptly and
accurately. The suppliers and distributors must have an opportunity to make a
fair profit.
They are responsible to the employees, the men and women who work with them
throughout the world. Everyone must be considered as an individual. They must
respect their dignity and recognize their merit. They must have a sense of
security in their jobs. Compensation must be fair and adequate, and working
conditions clean, orderly and safe. They must be mindful of ways to help the
employees fulfill heir family responsibilities. Employees must fee! free to
make suggestions and complaints, There must be equal opportunity for
employment, development and advancement for those qualified. They must provide
competent management, and their actions must be just and ethical.
They are responsible to the communities in which they live and work and to the
world community as well. They must be good citizens - support good works and
charities and bear the fair share of taxes. They must encourage civil
improvements and better health and education. They must maintain in good order
the property they are privileged to use, protecting the environment and natural
resources.
Chemical Inventor
In order to become a “CHEMICAL INVENTOR”
that expands operations on a global scale, Subject has pursued the unlimited potential
of chemistry and continued to raise challenges since its inception.
Subject is characterized by a flexible and advanced production system and fast,
reliable deliveries. There is a strong emphasis on quality assurance to meet
customers' demands for products of a uniform quality.
Subject is working on research and development based on the superior knowledge
and advanced technical capabilities adapted to diverse market needs. Further
they are creating new values in chemistry with drive and passion, in
consideration of the global environment.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.48.89 |
|
|
1 |
Rs.77.31 |
|
Euro |
1 |
Rs.67.78 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
Yes |
|
--LITIGATION |
YES/NO |
No |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
No |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
No |
|
--EXPORT ACTIVITIES |
YES/NO |
Yes |
|
--AFFILIATION |
YES/NO |
No |
|
--LISTED |
YES/NO |
No |
|
--OTHER MERIT FACTORS |
YES/NO |
Yes |
|
TOTAL |
|
49 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
>86 |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
71-85 |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
56-70 |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
41-55 |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
26-40 |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
11-25 |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
<10 |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.